Hexagon Nutrition IPO Day 1: Check GMP, Subscription Status & Key Highlights
The ₹138.87 crore Hexagon Nutrition IPO opened for subscription on June 5, 2026, with a price band of ₹42-₹45 per share. As of 11:10 AM on the first day of bidding, the issue was subscribed 0.21 times, while the grey market premium (GMP) was reported at around ₹10 per share.
Investors can participate in the offer until June 9, 2026. Following the close of the issue, the finalisation of the allotment basis is anticipated for June 10, 2026. The company is expected to make its debut on the BSE and NSE on June 12, 2026.
Hexagon Nutrition IPO - Issue Details
- Issue Type: Book Building IPO
- Total Issue Size: ₹138.87 crore
- Offer for Sale (OFS): 3.09 crore equity shares
- Face Value: ₹1 per equity share
- Price Band: ₹42 to ₹45 per share
- Lot Size: 333 shares
- Listing: NSE, BSE
- Book Building Lead Managers: Cumulative Capital Private Limited and Catalyst Capital Partners Private Limited.
- Registrar: KFin Technologies Limited
Explore other Upcoming IPOs on BSE and NSE.
Hexagon Nutrition IPO Timeline (Tentative)
The expected IPO schedule is as follows:
|
Event |
Tentative Date |
|
IPO Opens |
June 5, 2026 |
|
IPO Closes |
June 9, 2026 |
|
Basis of Allotment |
June 10, 2026* |
|
Initiation of Refund |
June 11, 2026 |
|
Credit of Shares to Demat Account |
June 11, 2026 |
|
Listing on BSE and NSE |
June 12, 2026* |
*Note - The allotment and listing dates are tentative and may be revised.
Hexagon Nutrition IPO Day 1 Subscription Status
[June 5, 2026, 11:10 AM]
|
Category |
Subscription (x) |
|
Qualified Institutional Buyers (QIBs) |
0.00x |
|
Non-Institutional Investors (NIIs) |
0.16x |
|
Retail Individual Investors (RIIs) |
0.35x |
|
Total |
0.21x |
Hexagon Nutrition IPO GMP Today
According to media reports, the Grey Market Premium (GMP) for the Hexagon Nutrition IPO stood at around ₹10 per share on June 5, 2026.
About Hexagon Nutrition Limited
Founded in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company engaged in the development and manufacture of micronutrient premixes, therapeutic formulations, ready-to-use foods, and wellness products.
The company's product portfolio is categorised into three main segments. These include clinical nutrition and branded wellness products (B2C), premix formulation solutions (B2B2C), ready-to-use foods (RUFs), and micronutrient powders (MNPs).
Hexagon Nutrition has established a worldwide footprint, supported by an international production facility in Tashkent, Uzbekistan, and three domestic units in India: Nasik, Chennai, and Thoothukudi.
Hexagon Nutrition recorded revenue of ₹324.9 crore and a net profit of ₹24.3 crore in FY25, a significant increase from the ₹297.7 crore and ₹12.2 crore reported in FY24. For the nine-month period ended December 31, 2025, the company achieved operational revenue of ₹267.5 crore and a profit after tax of ₹27.03 crore.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.